DOI: 10.1055/s-00043364

Pharmaceutical Fronts

References

Kovtun Y, Noordhuis P, Whiteman KR. et al.
IMGN779, a novel CD33-targeting antibody-drug conjugate with DNA-alkylating activity, exhibits potent antitumor activity in models of AML.

Mol Cancer Ther 2018;
17 (06) 1271-1279

Download Bibliographical Data

Access:
Access: